These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23808102)

  • 21. Data-mining law struck down. Supreme court sides with drug companies in Vermont ruling.
    Carlson J
    Mod Healthc; 2011 Jun; 41(26):8-9. PubMed ID: 21853604
    [No Abstract]   [Full Text] [Related]  

  • 22. Educational Outreach to Opioid Prescribers: The Case for Academic Detailing.
    Trotter Davis M; Bateman B; Avorn J
    Pain Physician; 2017 Feb; 20(2S):S147-S151. PubMed ID: 28226336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.
    Mintzes B; Barer ML; Kravitz RL; Bassett K; Lexchin J; Kazanjian A; Evans RG; Pan R; Marion SA
    CMAJ; 2003 Sep; 169(5):405-12. PubMed ID: 12952801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of educational outreach to improve evidence-based prescribing in Medicaid: a cautionary tale.
    Zillich AJ; Ackermann RT; Stump TE; Ambuehl RJ; Downs SM; Holmes AM; Katz B; Inui TS
    J Eval Clin Pract; 2008 Oct; 14(5):854-60. PubMed ID: 19018918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restrictions on pharmaceutical detailing reduced off-label prescribing of antidepressants and antipsychotics in children.
    Larkin I; Ang D; Avorn J; Kesselheim AS
    Health Aff (Millwood); 2014 Jun; 33(6):1014-23. PubMed ID: 24889951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications.
    Kopp SW; Bang HK
    Health Mark Q; 2000; 17(3):39-56. PubMed ID: 11010219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health plans keeping drug cost increases in check with programs that promote generics.
    Capitation Manag Rep; 2002 Jul; 9(7):101-3, 97. PubMed ID: 12164057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roe v. Wade reaffirmed, again.
    Annas GJ
    Hastings Cent Rep; 1986 Oct; 16(5):26-7. PubMed ID: 3771197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Significance and Role of Academic Detailing for Optimal Medication].
    Yamamoto M; Hirosawa I; Doi H
    Yakugaku Zasshi; 2019; 139(8):1073-1079. PubMed ID: 31366841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Commercial speech bruises health privacy in the Supreme Court.
    Allen AL
    Hastings Cent Rep; 2011; 41(6):8-9. PubMed ID: 22238895
    [No Abstract]   [Full Text] [Related]  

  • 32. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. National survey on the attitudes of Canadian physicians towards drug-detailing by pharmaceutical representatives.
    Strang D; Gagnon M; Molloy W; Bedard M; Darzins P; Etchells E; Davidson W
    Ann R Coll Physicians Surg Can; 1996 Dec; 29(8):474-8. PubMed ID: 12380577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Academic Detailing Has a Positive Effect on Prescribing and Decreasing Prescription Drug Costs: A Health Plan's Perspective.
    Ndefo UA; Norman R; Henry A
    Am Health Drug Benefits; 2017 May; 10(3):129-133. PubMed ID: 28626509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mining the human genome after Association for Molecular Pathology v. Myriad Genetics.
    Evans BJ
    Genet Med; 2014 Jul; 16(7):504-9. PubMed ID: 24357850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An innovative approach to educating medical students about pharmaceutical promotion.
    Wilkes MS; Hoffman JR
    Acad Med; 2001 Dec; 76(12):1271-7. PubMed ID: 11739058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A trojan horse goes to court: Bolger v. Youngs Drug Products Corp.
    Mason M
    Am J Law Med; 1984; 10(2):203-27. PubMed ID: 6528881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gifts and influence: Conflict of interest policies and prescribing of psychotropic medications in the United States.
    King M; Bearman PS
    Soc Sci Med; 2017 Jan; 172():153-162. PubMed ID: 27856120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Confidentiality of prescription drug information in the era of computers and managed care. McDonald-Merrill-Ketcham lecture.
    Lo B
    Spec Law Dig Health Care Law; 2001 Jun; (266):9-27. PubMed ID: 11434346
    [No Abstract]   [Full Text] [Related]  

  • 40. Principles of educational outreach ('academic detailing') to improve clinical decision making.
    Soumerai SB; Avorn J
    JAMA; 1990 Jan; 263(4):549-56. PubMed ID: 2104640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.